Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder? (2022)
Attributed to:
Manchester – Confidence in Concept 2019
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/ijms23094854
Publication URI: http://dx.doi.org/10.3390/ijms23094854
Type: Journal Article/Review
Parent Publication: International Journal of Molecular Sciences
Issue: 9